DexCom Backtesting

DXCM -- USA Stock  

USD 149.50  2.45  0.02%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of DexCom and determine expected loss or profit from investing in DexCom over given investment horizon. Additionally see DexCom Hype Analysis, DexCom Correlation, DexCom Valuation, DexCom Volatility as well as analyze DexCom Alpha and Beta and DexCom Performance.
Horizon     30 Days    Login   to change

DexCom 'What if' Analysis

November 18, 2018
No Change 0.00  0.0%
In 2 months and 2 days
January 17, 2019
If you would invest  0.00  in DexCom on November 18, 2018 and sell it all today you would earn a total of 0.00 from holding DexCom or generate 0.0% return on investment in DexCom over 60 days. DexCom is related to or competes with Agilent Technologies, Guardant Health, Laboratory, DarioHealth Corp, Exact Sciences, and Fluidigm. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ...

DexCom Upside/Downside Indicators

Downside Deviation4.23
Information Ratio0.0881
Maximum Drawdown13.96
Value At Risk(6.23)
Potential Upside5.5

DexCom Market Premium Indicators

Risk Adjusted Performance0.1524
Jensen Alpha0.3408
Total Risk Alpha0.3961
Sortino Ratio0.0803
Treynor Ratio0.2775

DexCom Backtested Returns

Macroaxis considers DexCom not too risky given 2 months investment horizon. DexCom secures Sharpe Ratio (or Efficiency) of 0.1624 which denotes the organization had 0.1624% of return per unit of risk over the last 2 months. Our philosophy towards predicting volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. By reviewing DexCom technical indicators you can presently evaluate if the expected return of 0.5547% is justified by implied risk. Please utilize DexCom Downside Deviation of 4.23, Mean Deviation of 2.56 and Coefficient Of Variation of 1317.93 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100 DexCom holds performance score of 10. The firm shows Beta (market volatility) of 1.0183 which denotes to the fact that DexCom returns are very sensitive to returns on the market. as market goes up or down, DexCom is expected to follow. Although it is vital to follow to DexCom historical returns, it is good to be conservative about what you can actually do with the information regarding equity current trending patterns. The philosophy towards predicting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. We have found twenty-one technical indicators for DexCom which you can use to evaluate performance of the firm. Please utilizes DexCom Jensen Alpha, Potential Upside as well as the relationship between Potential Upside and Skewness to make a quick decision on weather DexCom price patterns will revert.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.50) 
correlation synergy

Modest reverse predictability

DexCom has modest reverse predictability. Overlapping area represents the amount of predictability between DexCom time series from November 18, 2018 to December 18, 2018 and December 18, 2018 to January 17, 2019. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom price movement. The serial correlation of -0.5 indicates that about 50.0% of current DexCom price fluctuation can be explain by its past prices. Given that DexCom has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of DexCom for similar time interval.
Correlation Coefficient-0.5
Spearman Rank Test-0.12
Residual Average0.0
Price Variance186.59

DexCom lagged returns against current returns

 Current and Lagged Values 

DexCom regressed lagged prices vs. current prices

 Current vs Lagged Prices 

DexCom Lagged Returns

 Regressed Prices 

Did you try this?

Run Chance of Distress Now


Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Chance of Distress

DexCom Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for DexCom and Agilent Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see DexCom Hype Analysis, DexCom Correlation, DexCom Valuation, DexCom Volatility as well as analyze DexCom Alpha and Beta and DexCom Performance. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.